ScreenerHero

PDEXPro-Dex, Inc.

NAS · US · Healthcare · Medical Instruments & Supplies · pro-dex.com
65.67USD-1.90%Mkt Cap: 209.67M $P/E: 18.09

Pro-Dex, Inc. designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide. It offers autoclavable, battery-powered and electric, and multi-functio…

Industry Peers

Medical Instruments & Supplies
Screen all
ISRG
Intuitive Surgical, Inc.
$135.72BUSDP/E 43.4
EL
EssilorLuxottica Societe anonyme
$81.53BUSDP/E 30.5
BDX
Becton, Dickinson and Company
$52.30BUSDP/E 33.2
MDLN
Medline Inc. Class A Common Stock
$46.09BUSDP/E 42.8
ALC
Alcon AG
$35.59BUSDP/E 56.2
ALC
Alcon AG
$32.44BUSDP/E 55.0
RMD
ResMed Inc.
$33.40BUSDP/E 22.2
WST
West Pharmaceutical Services, Inc.
$24.85BUSDP/E 45.2
DIM
Sartorius Stedim Biotech
$20.46BUSDP/E 64.5
SRT3
Sartorius Aktiengesellschaft
$18.52BUSDP/E 86.9
STMN
Straumann Holding AG
$16.89BUSDP/E 40.2
SRT
Sartorius Aktiengesellschaft
$14.73BUSDP/E 69.1
SOLV
Solventum Corporation Common Stock
$15.25BUSDP/E 10.9
COO
The Cooper Companies, Inc.
$14.87BUSDP/E 64.6
BAX
Baxter International Inc.
$13.62BUSD
ALGN
Align Technology, Inc.
$11.55BUSDP/E 27.6
RGEN
Repligen Corporation
$10.22BUSDP/E 244.8
AVTR
Avantor, Inc.
$9.78BUSD
ATR
AptarGroup, Inc.
$8.57BUSDP/E 24.3
YPSN
Ypsomed Holding AG
$6.08BUSDP/E 24.8
HeadlineSourceTime
Older
Vivos Therapeutics, Inc. (VVOS) Reports Q2 Loss, Lags Revenue Estimates

Vivos Therapeutics (VVOS) delivered earnings and revenue surprises of +26.19% and -5.15%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Zacks
Aveanna Healthcare (AVAH) Beats Q2 Earnings and Revenue Estimates

Aveanna (AVAH) delivered earnings and revenue surprises of +29.41% and +3.62%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Zacks
Pro-Dex Inc (PDEX) Positioned to Strengthen with Zimmer’s mBos Robot Commercialization

Long Cast Advisers, an independent registered investment adviser, released its Q2 2026 investor letter. A copy can be downloaded here. The firm reported strong earnings in the second quarter, with results improving 20%, bringing year-to-date returns to +19%. While performance trailed the Russell 2000 and iShares US MicroCap ETF, it remained well ahead of the […]

IInsider Monkey
Dentsply International (XRAY) Beats Q2 Earnings and Revenue Estimates

Dentsply (XRAY) delivered earnings and revenue surprises of +44.44% and +1.60%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Zacks